The Balancing Act of Herd Immunity - Wealth vs Health

Harvard Suggest Intermittent Social Distancing Could Be More Effective

Harvard University researchers say an on-again, off-again approach to social distancing could be a more effective strategy to avoid overwhelming hospitals and to build herd immunity against the novel coronavirus — but other experts aren’t so sure.

An April study, conducted at Harvard University’s T.H. Chan School of Public Health, championed intermittent social distancing — measures that are periodically reimposed when cases reach certain levels.

According to the researchers’ modelling, as long as social distancing occurred between 25 per cent and 75 per cent of the time, the world could both build immunity and keep the health-care system from overloading.  Watch the video on this page.

Social distancing restrictions could be eased under various scenarios, according to the authors—if COVID-19 treatments become available, if hospitals can increase their intensive care bed capacity, if there’s aggressive contact tracing and quarantine, or if a vaccine is developed.
“I think social distancing interventions of some sort are going to have to continue, hopefully lightened and in conjunction with other interventions,” said Marc Lipsitch, professor of epidemiology and director of the Center for Communicable Disease Dynamics and co-senior author of the study, in an April 14 article in STAT.

Here is a video explaining how the no lockdown strategy and accelerated "herd immunity" might be working in Sweden but also explains the risks.   Sweden prefers to use the term "transmission" for fear that they are perceived as giving up on fighting the disease.  Sweden's strategy would mean their death toll will be higher earlier and lower later as herd immunity achieved.  Thus, Sweden would not likely experience a second wave of transmission in the fall and winter months.   



It also raises the question of how many people are actually following the stay at home orders
Here is a Twitter poll asking if Intermittent social distancing would be effective? 

These 2 Flu Vaccines Are Killing People in South Korea

SINGAPORE - Health authorities have advised against the use of two influenza vaccines - SKYCellflu Quadrivalent and VaxigripTetra - after people who received them in South Korea died.

No deaths associated with influenza vaccination have been recorded here, noted the Ministry of Health (MOH) and the Health Sciences Authority (HSA) on Sunday (Oct 25), adding: "This is a precautionary measure following reported deaths after influenza vaccination in South Korea."

Information from South Korean authorities noted that seven brands of influenza vaccine had been administered to the people who died in South Korea.

Two of the seven brands are available in Singapore: SKYCellflu Quadrivalent is manufactured by SK Bioscience and distributed here by AJ Biologics; VaxigripTetra is made by Sanofi Pasteur and locally distributed by Sanofi Aventis.

The HSA is assessing the implications of the reported deaths in South Korea and the MOH has told healthcare providers and medical practitioners to temporarily stop using the two vaccines.

But the two other vaccines that have been brought into Singapore for the influenza season can still be used, they added.

ike any medicines, vaccines can cause side effects, such as soreness and redness at the injection site, fever, headaches, muscle aches, fatigue and nausea.

"These side effects are generally mild and resolve on their own. In rare instances, a person may experience high fever or severe allergic reactions (such as breathing difficulty, wheezing and swelling around the eyes) and immediate medical attention should be sought," said the agencies.

They added that vaccines approved for use here have been evaluated by the HSA to ensure that they meet the required international standards of quality, safety and efficacy.

The HSA monitors vaccine safety through a monitoring system that draws on the network of local healthcare professionals and international regulatory counterparts to pick up adverse events suspected to be associated with the medications.

Related Articles

Popular Posts

Topics

Activist Advertising Air Quality Alchohol Antibody Antitrust Apple Apps Arizona Bankruptcy Banks Bars BBB Beaches Ben Shapiro Biden Big Pharma Bill Gates Blackmail blood clots Business California Cares Act CDC Censorship Chart Children China Class Action Closures CNN Contact Tracing Corruption Cover Up Data Deaths Doctors DOJ Dominion Drugs Education Election Elon Musk Email Enforcement Facebook Fake Laws Fake News Fake Tests Fake Vaccine False Positive Famotidine Fauci FBI FDA Fear Mongering Federal Reserve Feds Fines Florida Flu Flu Shots Fox Fraud Free Speech Freedom FTC Gavin Newsom Genome Glenn Beck Google Government Guillain-Barré Halloween Harvard Health Department Healthcare Herd Immunity Hospitals Hydroxychloroquine Insurance Investment IRS J&J Jeff Bezos Jobs LA County Lawsuits Leadership Lies Loans Local Laws Lockdown Los Angeles Map Masks Media Medicaid Melatonin Mental Health Michigan Minnesota Nashville New Jersey New York NFL Nursing Homes NY Post Opinion Opposing View Oppression Outdoors Parks Pennsylvania Phishing Placebo Pneumonia Politics Poll Pollution PPP Prevention Project Veritas Protest Rand Paul Real Estate Regeneron Relief Checks Remdesirvir Restaurants Restraining Order Rudy Giuliani Safegraph SBA Scams Schools Science Seniors Sidney Powell Social Distancing South Korea Sports Stadiums Stay at Home Study Substance Abuse Surveillance Sweden Symptoms Taxes Technology Testing Texas Tips Tony Bobulinski Transmission Treatment Trojan Horse Trump Tucker Carlson Twitter Tyranny Unemployment Vaccine Video Vitamin D Warren Buffett Whistleblower WHO Wisconsin Workers Comp Zinc